11
Participants
Start Date
October 31, 2015
Primary Completion Date
April 8, 2017
Study Completion Date
April 8, 2017
Glucobay (acarbose)
Se arm description
Januvia (sitagliptin)
Se arm description
Verapamil HEXAL (verapamil)
Se arm description
Victoza (liraglutide)
Se arm description
Signifor (pasireotide)
Se arm description
Continuous glucose monitoring (CGM)
Continuous glucose monitoring will be performed during 6 days of the treatment period.
Meal tolerance test (MTT)
A meal tolerance test will be performed at the end of the treatment period. The subjects will consume the liquid meal at baseline and blood will be drawn for continuous blood sampling.
Zealand University Hospital
OTHER